Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 3/3/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong John Berridge?

John C. Berridge

Senior Regulatory Consultant

Pfizer Inc

HQ Phone:  (212) 733-2323

Email: j***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Pfizer Inc

235 East 42Nd Street

New York City, New York,10017

United States

Company Description

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care produc...more

Web References(74 Total References)


ISPE Launches PQLI Initiative to Facilitate Implementation of ICH Q8 and Q9 Guidelines - Sommatech

sommatechconsulting.com [cached]

These sessions are critically important opportunities to understand the latest developments from those directly involved in ICH and to contribute to clarifying the issues and opportunities of implementation," according to John Berridge, Pfizer Ltd., UK, Steering Committee Advisor.
John Berridge, PhD, Senior Regulatory Consultant, Pfizer, Inc. (EFPIA Advisor, SC) Berlin Seminar Leaders will be John Berridge, Pfizer, UK, and Bruce Davis, AstraZeneca, UK. John Berridge, Pfizer Ltd., UK


Djicyice.com - Promoting quality in drug manufacturing: FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards

www.djicyice.com [cached]

If a manufacturer can demonstrate a good understanding of key product attributes (e.g., stability, bioavailability) and provide evidence that it can control critical variables and detect product deviations, regulatory authorities will be able to review applications in one review cycle, permit improvements in a manufacturing process without prior approval, and implement a risk-based inspection process, explains Pfizer Vice-President John Berridge.


Speakers' Biographies - INTERPHEX Asia 2009 ISPE Singapore Conference 2009

v1.interphexasia.showsite.rxnova.com [cached]

Dr. John Berridge
European Regulatory Affairs Advisor ISPE John retired from Pfizer Global Research & Development at Sandwich in January 2006 as Vice President of Pharmaceutical Sciences. He spent more than 31 years at Pfizer, starting as an Analytical Chemist, and ultimately responsible for all aspects of the product realisation disciplines of chemistry, pharmacy, analytical and regulatory CMC in Europe. His research interests have been directed towards high performance liquid chromatography, with special emphasis on the use of chemometrics. This research was recognised by the award of the Chromatographic Society's Jubilee medal in 1989. John was involved in the ICH processes from their inception until November 2007, representing EFPIA in the Quality topics discussions. He has contributed to guidelines on impurities in drug substances and their dosage forms, specifications, and the Common Technical Document (Quality): he was the Industry rapporteur for the pharmaceutical development guideline (Q8). In 1995 he was presented with an FIP IPS award for his outstanding contribution to industrial pharmacy and in 1997 he was awarded the Royal Pharmaceutical Society Chiroscience award for his services to the pharmaceutical industry. John now acts as an independent consultant and as European Regulatory Affairs Advisor to ISPE. John will be presenting in Manufacturing Excellence: "Product Quality Lifecycle Implementation (PQLI) initiative - An Update" on 2 June 2009, Tuesday.


www2.ispe.org

John Berridge
John Berridge John Berridge, PhD, retired from Pfizer Global Research and Development at Sandwich at the end of January 2006 as vice president of pharmaceutical sciences. He spent more than 31 years at Pfizer, starting as an analytical chemist, and more recently responsible for all aspects of chemistry, pharmacy, analytical, and regulatory CMC in Europe. His research interests have been directed toward high-performance liquid chromatography, with special emphasis on the use of chemometrics to aid method development. More than 40 papers and a book have been published and this research has been recognized by the award of the Chromatographic Society's Jubilee medal in 1989. Berridge has been involved in the ICH processes from their inception, representing EFPIA in the quality topics discussions. He has contributed to guidelines on impurities in drug substances and their dosage forms, specifications, was the industry rapporteur for the Common Technical Document (Quality) and is currently the industry rapporteur for the pharmaceutical development guideline (Q8). At FIP's 55th World Congress in Stockholm in 1995 he was presented with an IPS award for his outstanding contribution to industrial pharmacy, and in September 1997 he was awarded the Royal Pharmaceutical Society Chiroscience award for his services to the pharmaceutical industry and for his work within ICH. Berridge now works as a consultant, representing Pfizer at EFPIA, and thus will continue to support the ICH activities.


www.pharmamanufacturing.com

Ellsworth joins ISPE's two other Regulatory Affairs Advisors, John Berridge and Bob Tribe.John Berridge, PhD, is ISPE's European Regulatory Affairs Advisor, assisting ISPE in its interactions with European regulatory authorities as well as helping to move forward ISPE's new Product Quality Lifecycle Implementation (PQLI) initiative.Berridge retired from Pfizer Global Research and Development at Sandwich, England at the end of January 2006 as European Vice President of Pharmaceutical Sciences.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory